Ebola Bundibugyo Vaccines in Development Four Months Before Outbreak
An Ebola outbreak in the Ituri province of the Democratic Republic of the Congo (DRC) was confirmed by the Africa Centers for Disease Control and Prevention (Africa CDC) on May 15, 2026. Through laboratory analysis, health officials confirmed that the outbreak is caused by the Bundibugyo ebola strain, for which there is no vaccine currently […]
Ebola Outbreak Pushing Development of Vaccines for Bundibugyo Strain
The current outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) and Uganda which began only a couple of weeks ago is already reportedly the third largest in history and, according to the World Health Organization’s (WHO) Director-General Tedros Adhanom Ghebreyesus, “spreading rapidly,” with more than 900 suspected cases of the […]
Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
FDA Launches New Consolidated Adverse Event Monitoring System
The U.S. Food and Drug Administration (FDA) has announced the launch of a new Adverse Event Monitoring System (AEMS) that consolidates adverse event reporting systems for different types of products licensed by the FDA, including the Vaccine Adverse Event Reporting System (VAERS) that was created under the 1986 National Childhood Vaccine Injury Act (NCVIA). The […]